Are there medical treatments for age-related penis shrinkage?

Checked on January 18, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Age-related penile shrinkage (penile atrophy) has multiple causes and is sometimes reversible: treatments exist that can slow, partly reverse, or compensate for loss of length depending on the cause, but no single universally effective “restorative” pill exists and some options remain experimental or surgical [1] [2] [3]. Effective approaches focus on treating underlying drivers—vascular disease, low testosterone, disuse/erectile dysfunction, Peyronie’s disease, or prostate cancer treatments—and range from lifestyle and medical therapies to devices and surgical prostheses [4] [5] [6].

1. Why penises can shrink with age — a short primer on causes

Penile shortening is linked to aging-related hormone changes (declining testosterone), reduced blood flow from vascular disease or obesity, disuse atrophy caused by fewer erections, scar formation from Peyronie’s disease, and treatments for prostate cancer such as surgery, radiation, or androgen-deprivation therapy [2] [5] [3] [7].

2. Non-surgical, evidence-backed treatments that can help

Conservative measures with clinical support include treating erectile dysfunction (oral PDE5 inhibitors, penile injections, vacuum erection devices) to restore regular erections and reduce disuse atrophy, lifestyle changes that improve circulation (weight loss, smoking cessation, exercise), and testosterone replacement when clear hypogonadism is present; these can slow or partially reverse shrinkage in some men [8] [4] [2]. Traction devices and supervised stretching have demonstrated benefit for length restoration in some Peyronie’s and post-prostatectomy contexts, and shockwave therapy is being used to stimulate local circulation though the evidence base is still emerging [9] [6] [5].

3. Disease-specific medical interventions: Peyronie’s and cancer-related atrophy

For Peyronie’s disease—the scar-driven curvature that often shortens the penis—there is a U.S. Food and Drug Administration–approved enzyme, collagenase clostridium histolyticum (Xiaflex), plus intralesional therapies, surgery, and traction that aim to reduce scar and restore length or function [1] [10]. Post-prostatectomy or androgen-deprivation shrinkage sometimes recovers over months to years with penile rehabilitation (vacuum devices, medications, guided therapy), but severe or persistent loss after cancer treatment may require device-based or surgical solutions [1] [3].

4. Surgical and device solutions: prostheses and implants

When conservative measures fail or erectile dysfunction is irreversible, penile prosthesis implantation is a standard surgical option to restore function and, in some patients, perceived length; guidelines note implants are primarily for restoring erectile function rather than reliably increasing length and emphasize careful patient selection [6]. Surgical lengthening or augmentation exists but carries risks and variable outcomes; the literature shows mixed results on true size gain versus functional restoration [7] [6].

5. Experimental therapies and the lines between promise and marketing

Emerging approaches—stem cell therapy, gene treatments, topical nanoparticles, and regenerative techniques—appear in preclinical and small human studies as potential ways to reverse fibrosis and tissue loss, but remain investigational and not proven for routine clinical use [3]. Commercial clinics and aesthetic providers sometimes promote off-label injections (botulinum toxin) or packages promising “penile atrophy treatment,” and such offerings may reflect marketing more than solid evidence; careful skepticism is warranted and claims should be weighed against peer-reviewed data [11] [12].

6. How to make sense of options and the limits of the evidence

Choice of treatment depends entirely on cause: vascular/disuse problems favor rehabilitation, ED drugs, devices and lifestyle fixes; hypogonadism may justify testosterone only when medically indicated; Peyronie’s has specific approved treatments; irreversible tissue loss may require prosthesis or specialist surgery [8] [2] [6]. Clinical guidelines (e.g., EAU) and peer-reviewed reviews caution that hormones are not endorsed solely to increase penile size in adults and that many promising avenues are preliminary—patients should consult urology specialists and scrutinize commercial claims [6] [3].

Want to dive deeper?
What are the comparative outcomes of penile traction versus prosthesis implantation for post-prostatectomy shortening?
What does the 2025 EAU guideline say about testosterone therapy and penile atrophy?
Which investigational regenerative therapies for penile fibrosis have human trial data and what were their results?